S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: Neuropathix, Inc. [NPTX]

交易所: OTC 部门: Healthcare 工业: Biotechnology
最后更新时间14 Jun 2023 @ 00:01

0.00% $ 0.000300

Live Chart Being Loaded With Signals

Commentary (14 Jun 2023 @ 00:01):

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform...

Stats
今日成交量 10 000.00
平均成交量 13 596.00
市值 28 143.00
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.00750
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2022-06-06 Petkanas Dean Sell 10 000 Common Stock
2022-06-07 Petkanas Dean Sell 50 000 Common Stock
2022-06-08 Petkanas Dean Sell 21 836 Common Stock
2022-06-09 Petkanas Dean Sell 238 164 Common Stock
2022-06-13 Petkanas Dean Sell 300 000 Common Stock
INSIDER POWER
-100.00
Last 56 transactions
Buy: 20 518 991 | Sell: 5 700 000

音量 相关性

長: -0.12 (neutral)
短: 0.00 (neutral)
Signal:(47.122) Neutral

Neuropathix, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Neuropathix, Inc. 相关性 - 货币/商品

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Neuropathix, Inc. 财务报表

Annual 2021
营收: $183 477
毛利润: $0.00 (0.00 %)
EPS: $-0.0480
FY 2021
营收: $183 477
毛利润: $0.00 (0.00 %)
EPS: $-0.0480
FY 2020
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.0600
FY 2019
营收: $126 027
毛利润: $0.00 (0.00 %)
EPS: $-0.0500

Financial Reports:

No articles found.

Neuropathix, Inc.

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。